Cargando…

Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?

Detalles Bibliográficos
Autor principal:	Vaillant, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227515/ https://www.ncbi.nlm.nih.gov/pubmed/35746664 http://dx.doi.org/10.3390/v14061193

Ejemplares similares

Subviral Agents
por: STRAUSS, JAMES H., et al.
Publicado: (2008)

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
por: Gomez-Escobar, Elsa, et al.
Publicado: (2021)

Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)

Subviral particle as vaccine and vaccine platform
por: Tan, Ming, et al.
Publicado: (2014)

An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine
por: Krauter, Steffi, et al.
Publicado: (2022)

Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
por: Barra, Fabio, et al.
Publicado: (2019)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Where We Are and Where We Are Going in Nut Research
por: Salas-Salvadó, Jordi, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Telemedicine in ophthalmology - where are we and where are we going?
por: Pîrvulescu, Ruxandra
Publicado: (2023)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Anesthesiology and the Difficult Airway – Where Do We Currently Stand?
por: Richtsfeld, Martina, et al.
Publicado: (2017)

Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We?
por: Bridi, Guilherme das Posses, et al.
Publicado: (2023)

Respondent driven sampling—where we are and where should we be going?
por: White, Richard G, et al.
Publicado: (2012)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014)

Horizons of Psychiatric Genetics and Epigenetics: Where Are We and Where Are We Heading?
por: Mostafavi Abdolmaleky, Hamid
Publicado: (2014)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Craniofacial genetics: Where have we been and where are we going?
por: Weinberg, Seth M., et al.
Publicado: (2018)

Bariatric and metabolic surgery in Asia: Where are we, and where are we going?
por: Yasuda, Kazuki
Publicado: (2018)

COVID-19 Vaccination. Where Are We and Where Should We Go?
por: Peña-Otero, David
Publicado: (2022)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Crossing Surgical Borders: Where are We, Where are We Going and Can We Find the Way?
por: Khunger, Niti
Publicado: (2016)

Where are we going?
por: Pawl, Ronald P.
Publicado: (2010)

Tuberculosis: where are we?
por: Mello, Fernanda Carvalho de Queiroz, et al.
Publicado: (2018)

Psychopharmacology Today: Where are We and Where Do We Go From Here?
por: Schwartz, Thomas L.
Publicado: (2010)

Health Psychology: Where Are We And Where Do We Go From Here?
por: Kaplan, Robert M.
Publicado: (2009)

Cancer Care and the Role of Psychosocial Oncology: Where are We and Where are We Going?
por: Bultz, Barry D.
Publicado: (2016)

Sequencing Technologies and Analyses: Where Have We Been and Where Are We Going?
por: Bansal, Vikas, et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Micronutrients in Maternal and Infant Health: Where We Are and Where We Should Go
por: Yu, Yunxian
Publicado: (2023)

Pediatric chylothorax: where we’ve been and where we’re going
por: Winder, Melissa, et al.
Publicado: (2023)

Activation of ERAD Pathway by Human Hepatitis B Virus Modulates Viral and Subviral Particle Production
por: Lazar, Catalin, et al.
Publicado: (2012)

Characterization Of The Interaction Between Subviral Particles Of Hepatitis B Virus And Dendritic Cells – In Vitro Study
por: Farag, Mohamed MS, et al.
Publicado: (2019)

Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain
por: Tabata, Koshiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjgsqjq65mb8u17h1prlu9f0us